Silva, J.M.F.d.; Silva, D.M.e.; Costa, D.d.S.; Amaro, M.C.; Cajas, R.A.; de Moraes, J.; Tavares, G.D.; Da Silva Filho, A.A.
Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection. Pharmaceutics 2026, 18, 694.
https://doi.org/10.3390/pharmaceutics18060694
AMA Style
Silva JMFd, Silva DMe, Costa DdS, Amaro MC, Cajas RA, de Moraes J, Tavares GD, Da Silva Filho AA.
Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection. Pharmaceutics. 2026; 18(6):694.
https://doi.org/10.3390/pharmaceutics18060694
Chicago/Turabian Style
Silva, José Márcio Fernandes da, Dominique Mesquita e Silva, Danilo de Souza Costa, Monique C. Amaro, Rayssa A. Cajas, Josué de Moraes, Guilherme Diniz Tavares, and Ademar Alves Da Silva Filho.
2026. "Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection" Pharmaceutics 18, no. 6: 694.
https://doi.org/10.3390/pharmaceutics18060694
APA Style
Silva, J. M. F. d., Silva, D. M. e., Costa, D. d. S., Amaro, M. C., Cajas, R. A., de Moraes, J., Tavares, G. D., & Da Silva Filho, A. A.
(2026). Nanostructured Lipid Carriers Enable In Vivo Efficacy of Parthenolide in Schistosoma mansoni Infection. Pharmaceutics, 18(6), 694.
https://doi.org/10.3390/pharmaceutics18060694
